Organizing for innovation: towards successful translational research

Trends in Biotechnology

Volumn 27, Issue 10, 2009, Pages 558-561

  West, Will ^a   Nightingale, Paul ^b  

^a CellCentric   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY FIRMS; DRUG DISCOVERY; ORGANIZATIONAL CHANGE; ORGANIZATIONAL COMPLEXITY; PHARMACEUTICAL INDUSTRY; PRODUCTIVITY CRISIS; TECHNOLOGY TRANSFER OFFICES; TRANSLATIONAL RESEARCH;

DRUG PRODUCTS PLANTS; MANAGEMENT; TECHNOLOGICAL FORECASTING; TECHNOLOGY TRANSFER;

RESEARCH;

ARTICLE; BIOTECHNOLOGY; DECENTRALIZATION; DRUG INDUSTRY; DRUG RESEARCH; GOVERNMENT REGULATION; MEDICAL EDUCATION; ORGANIZATIONAL DEVELOPMENT; ORGANIZATIONAL STRUCTURE; PRIORITY JOURNAL; PRODUCTIVITY;

BIOMEDICAL RESEARCH; DRUG DISCOVERY; DRUG INDUSTRY; RESEARCH; UNIVERSITIES;

EID: 69749097396     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2009.06.007     Document Type: Article

References (12)

1. Anonymous (2008) Shooting down cancer. Economist 388(8597), 15
2. Overington J.P., et al. How many drug targets are there?. Nat. Rev. Drug Discov. 5 (2006) 993-996
3. Garnier J.-P. Rebuilding the R&D engine in big pharma. Harv. Bus. Rev. 86 5 (2008) 68-70
4. Bonabeau E., et al. A more rational approach to new-product development. Harv. Bus. Rev. 86 3 (2008) 96-102
5. Hopkins M.M., et al. The myth of the biotech revolution: an assessment of technological, clinical and organisational change. Res. Pol. 36 (2007) 566-589
6. Chisholm J. Innovation and the Wealth of Nations (2008), Babraham Institute Bio-enterprise Award Lecture
7. Nightingale P. Economies of scale in experimentation: knowledge and institutions in pharmaceutical R&R. Ind. Corp. Change 9 (2000) 315-359
8. Dougherty D. Trapped in the 20th century? Why models of organizational learning, knowledge and capabilities do not fit biopharmaceuticals, and what to do about that. Manage. Learn. 38 (2007) 265-270
9. Kaplan, S. and Murray, F. Technology, organizations and institutions in the construction of economic value: the core of biotechnology. In Technology and Organization (Research in the Sociology of Organizations) (Griffiths, D, et al., eds), Elsevier (in press)
10. Pisano G.P. Can science be a business? Lessons from biotech. Harv. Bus. Rev. 84 10 (2006) 114-124
11. Lambert R. The Lambert Review of Business University Collaboration (2003), HM Treasury
12. Wadman M. The winding road from ideas to income. Nature 453 (2008) 830-831